Compare Abeona Therapeutics Inc (ABEO) vs Quanta Services Inc (PWR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Quanta Services Inc — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Quanta Services Inc trades at $666.12 (market cap $98.56B). The key difference: Quanta Services Inc is far larger — about 264× Abeona Therapeutics Inc's market cap, and Quanta Services Inc pays a 0.07% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | PWR | |
|---|---|---|
Market Cap | $373.32M | $98.56B |
Sector | Health | Industrials |
52-Week High | $7.23 | $785.24 |
52-Week Low | $4.17 | $372.50 |
Enterprise Value | $228.22M | $104.51B |
Dividend Yield | — | 0.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Quanta Services (PWR) trades at $656.79, down 1.72% amid bearish technical signals, though it maintains strong analyst support with 27 buy ratings. The company shows robust revenue growth, reaching $28.48B in 2025, with consistent earnings beats in recent quarters. However, premium valuation metrics including a P/E of 92.46 and EV/EBITDA of 39.58 present challenges. Recent news highlights infrastructure demand drivers but questions valuation sustainability after a 79% yearly gain.
PWR's outlook is supported by record backlog and infrastructure spending tailwinds, but execution risks and high valuation create near-term headwinds. The consensus price target of $842.67 suggests 28% upside potential, though investors must weigh growth prospects against current premium multiples and technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
